Search results for "Killer Cell"

showing 10 items of 154 documents

Effects of in vitro treatment with fluticasone propionate on natural killer and lymphokine-induced killer activity in asthmatic and healthy individua…

2001

Background: Topical corticosteroids are beneficial in the treatment of allergic respiratory disorders; they exert effects on a number of cells involved in allergic inflammatory reactions. On the other hand, major histocompatibility complex (MHC)-unrestricted cytotoxicity (i.e., natural killer [NK] cell activity) may play a role in the inflammatory allergic reaction. The objective was to gain insight into the mechanisms of the therapeutic effects of fluticasone propionate (FP), an inhaled corticosteroid used in asthma and rhinitis therapy. Therefore, we evaluated the NK and lymphokine-activated killer (LAK) activity of effector cells in vitro treated or not with FP. Methods: Evaluations were…

AllergyLymphocyteImmunologychemical and pharmacologic phenomenaFluticasone propionateNatural killer cellInterferonmedicineImmunology and AllergyHumansAnti-Asthmatic AgentsKiller Cells Lymphokine-ActivatedFluticasonebusiness.industryLymphokineInterleukinInterferon-alphamedicine.diseaseAsthmaAndrostadienesKiller Cells Naturalmedicine.anatomical_structureImmunologyFluticasonebusinessmedicine.drugAllergy
researchProduct

Allogeneic stem cell transplantation for renal cell carcinoma

2011

Allogeneic hematopoietic stem cell transplantation from a compatible donor has been utilized as adoptive immunotherapy in metastatic, cytokine-refractory renal cell carcinoma (RCC). Since the year 2000, several investigators have established that RCC is susceptible to a graft-versus-tumor effect: they reported that patients with renal cancer may have partial or complete disease responses, in the 20-40% range, after allogeneic transplantation following a reduced-intensity regimen. However, transplant-related mortality is still high in the 10-20% range, and responses are rarely durable. Experimental evidence suggests that donor-derived T cells and natural killer cells are the main mediators o…

Allogeneic transplantationT-Lymphocytesmedicine.medical_treatmentAntineoplastic AgentsHematopoietic stem cell transplantationurologic and male genital diseasesMinor histocompatibility antigenHumansTransplantation HomologousMedicineCytotoxic T cellPharmacology (medical)Molecular Targeted TherapyNeoplasm MetastasisCarcinoma Renal Cellbusiness.industryHematopoietic Stem Cell TransplantationImmunotherapyCombined Modality TherapyKidney NeoplasmsTissue DonorsKiller Cells NaturalTransplantationOncologyImmunologyStem cellbusinessCD8Expert Review of Anticancer Therapy
researchProduct

Aminobisphosphonate-activated γδ T cells in immunotherapy of cancer: doubts no more

2008

BACKGROUND: Activated V gamma 9 V delta 2 T cells are able to kill most tumour cells because of recognition by T cell receptor and natural killer receptors. OBJECTIVE: We discuss the possibility that the intentional activation of gammadelta T cells in vivo by aminobisphosphonates may represent a promising target for the design of novel and highly innovative immunotherapy in cancer patients. METHODS: The antitumoral effects of gammadelta T cells both in vitro and in vivo have been demonstrated suggesting a new therapeutic approach for translation into the clinical setting. RESULTS/CONCLUSION: V gamma 9 V delta 2 T lymphocytes represent a particularly interesting target for immunotherapeutic …

Aminobisphosphonate Gamma delta T cells cancermedicine.medical_treatmentT cellClinical BiochemistryReceptors Antigen T-CellAntineoplastic AgentsModels BiologicalInterleukin 21Immune systemAntigenT-Lymphocyte SubsetsIn vivoNeoplasmsDrug DiscoveryAnimalsHumansCytotoxic T cellMedicinePharmacologyClinical Trials as TopicDiphosphonatesbusiness.industryT-cell receptorReceptors Antigen T-Cell gamma-deltaImmunotherapyKiller Cells Naturalmedicine.anatomical_structureImmune SystemImmunologyInterleukin-2ImmunotherapybusinessImmunologic MemoryExpert Opinion on Biological Therapy
researchProduct

Embryonic neural cell adhesion molecules on human natural killer cells

1989

The neural cell adhesion molecules (NCAM) are surface glycoproteins that were first described in brain tissue. NCAM mediate adhesion in a variety of cell-cell interactions. In the present study we show that the so-called "embryonic" NCAM, i.e., the highly polysialylated forms of these proteins, are expressed on natural killer cells and some CD3+ cells in man. Homotypic binding of NCAM, believed to be of importance for cell-cell adhesion in neural tissues, appears not to be essential for NK cell-mediated killing. Yet, NCAM might be involved in NK cell migration, homing or related functions.

Antigens Differentiation T-LymphocyteCD3 ComplexCell Adhesion Molecules NeuronalT-LymphocytesCD3Blotting WesternImmunologyReceptors Antigen T-CellChromatography AffinityNatural killer cellCell–cell interactionmedicineHumansImmunology and AllergybiologyCell adhesion moleculeAntibodies MonoclonalCell migrationFlow CytometryPrecipitin TestsMolecular biologyEmbryonic stem cellCell biologyKiller Cells Naturalmedicine.anatomical_structurenervous systembiology.proteinNeural cell adhesion moleculeHoming (hematopoietic)European Journal of Immunology
researchProduct

Differences in non-MHC restricted cytotoxic activities of human peripheral blood lymphocytes after transfusion with allogeneic leukocytes or platelet…

1990

Abstract MHC-unrestricted cytotoxic activity of peripheral blood lymphocytes (PBL) from 4–6 healthy donors was investigated before and after transfusion with allogeneic leukocytes or platelets. Natural killer and lectin-dependent cellular cytotoxicity (LDCC) of PBL was tested against K562 and Raji target cells in a 4-h and 16-h 51 Cr-release assay, respectively. After allotransfusion with leukocytes, we found increased cytotoxic activity of each donor's PBL against all the three targets on day 3 or 7. The highest non-specific cytotoxic activity was detected against the relatively NK resistant Raji target cells. The increase of cytotoxic activity was lowest against the LDCC target (PHA-treat…

Blood PlateletsCytotoxicity ImmunologicMaleImmunologyFluoroimmunoassaychemical and pharmacologic phenomenaHuman leukocyte antigenPlatelet TransfusionMajor histocompatibility complexNeopterinNatural killer cellImmune systemAntigenmedicineLeukocytesImmunology and AllergyCytotoxic T cellHumansPlateletBlood TransfusionLymphocytesCytotoxicitybiologyHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHematologyCytotoxicity Tests ImmunologicIntercellular Adhesion Molecule-1BiopterinKiller Cells NaturalLeukocyte Transfusionmedicine.anatomical_structureImmunologybiology.proteinInterleukin-2Immunizationbeta 2-MicroglobulinCell Adhesion MoleculesImmunobiology
researchProduct

Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response

2003

Abstract An optimal antitumoral immune response requires the activation of both CD8 + and CD4 + T lymphocytes by the peptide antigen presentation via the human leukocyte antigen (HLA) class I and class II molecules, respectively. Downregulation or loss of HLA molecules has been found in human renal cell carcinoma (RCC) and provides a strategy of these tumors to evade T-cell mediated immunosurveillance. In addition, a tumor-specific upregulation of HLA-G has been recently described in RCC, which also leads to an impaired immune response. We here summarize the frequency of the constitutive and/or interferon-γ (IFN-γ) inducible expression of nonclassical HLA class Ib antigens in RCC cell lines…

Blotting WesternImmunologyHuman leukocyte antigenBiologyurologic and male genital diseasesInterferon-gammaImmune systemAntigenDownregulation and upregulationHLA AntigensInterferonTumor Cells CulturedmedicineHumansImmunology and AllergyRNA MessengerCarcinoma Renal CellHLA-G AntigensKidneyReverse Transcriptase Polymerase Chain ReactionHistocompatibility Antigens Class IAntibodies MonoclonalGeneral MedicineFlow CytometryKidney NeoplasmsRecombinant ProteinsUp-RegulationGene Expression Regulation NeoplasticKiller Cells NaturalImmunosurveillanceBlotting Southernmedicine.anatomical_structureImmunologyCD8T-Lymphocytes Cytotoxicmedicine.drugHuman Immunology
researchProduct

Immunelectronmicroscopic characterization of T4 and T8 lymphocytes and natural killer cells in neuronal ceroid-lipofuscinosis.

1995

CD4+, CD8+, and CD56+ cells were isolated with the immunomagnetic separation technique from peripheral blood mononuclear cells (PBMC) of 3 patients with neuronal ceroid-lipofuscinosis : one patient each with infantile (INCL), late infantile (LINCL), and juvenile (JNCL) neuronal ceroid-lipofuscinoses, all studied by light (LM) and electron (EM) microscopy. To compare the pathology of these cells with affected cells in other types of lysosomal diseases, the separation was also performed with PBMC of 1 patient with mucolipidosis (ML) type II, 2 patients with mucopolysaccharidosis (MPS) type I, and 4 patients with MPS type III. Disease-specific lysosomal inclusions were identified in CD4+, CD8+…

CD4-Positive T-LymphocytesAdolescentMucolipidosisLymphocyteMucopolysaccharidosisInfantBiologyCD8-Positive T-LymphocytesMucopolysaccharidosesmedicine.diseaseImmunomagnetic separationMolecular biologyPeripheral blood mononuclear cellKiller Cells Naturalmedicine.anatomical_structureNeuronal Ceroid-LipofuscinosesChild PreschoolImmunologymedicineHumansNeuronal ceroid lipofuscinosisLysosomesMicroscopy ImmunoelectronGenetics (clinical)CD8American journal of medical genetics
researchProduct

Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis

1988

Human T lymphocytes infiltrating the liver in chronic active hepatitis B (CAH-B) and primary biliary cirrhosis were isolated from liver biopsy cores, cloned by limiting dilution technique and expanded in vitro. Phenotypic and functional analysis demonstrates that this tissue infiltrate represents a heterogeneous cell population. However, when compared to peripheral blood lymphocytes of the same patients, a marked enrichment for T8+ cytotoxic T cells was found to exist at a local site in both types of chronic liver disease. These data provide support for the notion that liver cell injury in CAH-B and PBC may be mediated by a common immunologic mechanism likely executed by cells of the T line…

CD4-Positive T-LymphocytesCytotoxicity ImmunologicPathologymedicine.medical_specialtyT-LymphocytesBiliary cirrhosisImmunologyChronic liver diseasePrimary biliary cirrhosismedicineHumansImmunology and AllergyCytotoxic T cellHepatitis Chronicmedicine.diagnostic_testLiver Cirrhosis Biliarybusiness.industryLiver cellHepatobiliary diseaseAntibodies MonoclonalT lymphocyteHepatitis Bmedicine.diseaseClone CellsKiller Cells NaturalLiver biopsyImmunologybusinessT-Lymphocytes CytotoxicEuropean Journal of Immunology
researchProduct

Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancer

2010

Background: Patients with inflammatory bowel disease (IBD) have a markedly increased risk to develop colon cancer, but there are only limited data about the host antitumor response in such colitis-associated cancer. In the present study we aimed at assessing the role of perforin-dependent effector mechanisms in the immune response in a murine model of colitis-associated colon cancer. Methods: Wildtype and perforin-deficient mice were analyzed in a mouse model of colitis-associated colon cancer using azoxymethane (AOM) and dextran sodium sulfate (DSS). Results: Tumors of wildtype mice showed infiltration of CD4+, CD8+ T cells, natural killer (NK) cells, high numbers of apoptotic cells, and e…

CD4-Positive T-LymphocytesCytotoxicity ImmunologicPore Forming Cytotoxic ProteinsT-LymphocytesMedizinInflammationCD8-Positive T-LymphocytesBiologymedicine.disease_causeInflammatory bowel diseaseMiceImmune systemmedicineAnimalsImmunology and AllergyCytotoxic T cellIntestinal MucosaColitisReverse Transcriptase Polymerase Chain ReactionPerforin DeficiencyDextran SulfateGastroenterologyColitismedicine.diseaseSpecific Pathogen-Free OrganismsKiller Cells NaturalMice Inbred C57BLDisease Models AnimalPerforinChronic DiseaseColonic NeoplasmsImmunologybiology.proteinmedicine.symptomCarcinogenesisInflammatory Bowel Diseases
researchProduct

Deficiency in the Transcription Factor Interferon Regulatory Factor (Irf)-2 Leads to Severely Compromised Development of Natural Killer and T Helper …

2000

Interferon (IFN) regulatory factor (IRF)-2 was originally described as an antagonist of IRF-1–mediated transcriptional regulation of IFN-inducible genes. IRF-1−/− mice exhibit defective T helper type 1 (Th1) cell differentiation. We have used experimental leishmaniasis to show that, like IRF-1−/− mice, IRF-2−/− mice are susceptible to Leishmania major infection due to a defect in Th1 differentiation. Natural killer (NK) cell development is compromised in both IRF-1−/− and IRF-2−/− mice, but the underlying mechanism differs. NK (but not NK+ T) cell numbers are decreased in IRF-2−/− mice, and the NK cells that are present are immature in phenotype. Therefore, like IRF-1, IRF-2 is required for…

CD4-Positive T-LymphocytesMaleInterferon Regulatory Factor 2Cellular differentiationImmunologyLeishmaniasis CutaneousBiologyNitric OxideTh1MiceInterleukin 21Immune systemBone MarrowInterferonmedicineAnimalsImmunology and AllergyLymphocyte CountLeishmania majorInterleukin-15Mice KnockoutLeishmaniaMice Inbred BALB Cnatural killer cellsCell DifferentiationTh1 CellsInterleukin-12Cell biologyDNA-Binding ProteinsKiller Cells NaturalMice Inbred C57BLRepressor ProteinsDisease Models AnimalInterleukin 15interferon regulatory factorImmunologyInterleukin 12FemaleOriginal ArticleDisease SusceptibilityInterferon Regulatory Factor-2interleukin 15Transcription FactorsInterferon regulatory factorsmedicine.drugJournal of Experimental Medicine
researchProduct